These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


366 related items for PubMed ID: 9324180

  • 1. Advances in the treatment and prophylaxis of Pneumocystis carinii pneumonia.
    Warren E, George S, You J, Kazanjian P.
    Pharmacotherapy; 1997; 17(5):900-16. PubMed ID: 9324180
    [Abstract] [Full Text] [Related]

  • 2. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ, Hauptman SP.
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C, McAfee S, Sackstein R, Finkelstein D, Fishman J, Spitzer T.
    Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
    [Abstract] [Full Text] [Related]

  • 5. Treatment of Pneumocystis carinii pneumonia in adults with AIDS.
    Deresinski SC.
    Semin Respir Infect; 1997 Jun; 12(2):79-97. PubMed ID: 9195673
    [Abstract] [Full Text] [Related]

  • 6. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC, Rimland D.
    Pharmacotherapy; 1996 Jun; 16(6):1030-8. PubMed ID: 8947975
    [Abstract] [Full Text] [Related]

  • 7. Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.
    Safrin S.
    Semin Respir Infect; 1993 Jun; 8(2):96-103. PubMed ID: 8278684
    [Abstract] [Full Text] [Related]

  • 8. Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: pathophysiology, therapy, and prevention.
    Montgomery AB.
    Semin Respir Infect; 1989 Jun; 4(2):102-10. PubMed ID: 2664934
    [Abstract] [Full Text] [Related]

  • 9. [Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment].
    González-García J, Rubio García R, Antela López A, García Alcaide F.
    Enferm Infecc Microbiol Clin; 1998 Jun; 16 Suppl 1():36-44. PubMed ID: 9859618
    [Abstract] [Full Text] [Related]

  • 10. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
    Korraa H, Saadeh C.
    South Med J; 1996 Mar; 89(3):272-7. PubMed ID: 8604455
    [Abstract] [Full Text] [Related]

  • 11. Optimizing PCP therapy.
    Torres G, Cadman J.
    GMHC Treat Issues; 1997 Oct; 11(10):3-5. PubMed ID: 11364821
    [Abstract] [Full Text] [Related]

  • 12. Pneumocystis carinii pneumonia in human immunodeficiency virus-infected infants and children.
    Goodwin SD.
    Pharmacotherapy; 1993 Oct; 13(6):640-6. PubMed ID: 8302691
    [Abstract] [Full Text] [Related]

  • 13. Pneumocystis carinii pneumonia prophylaxis during pregnancy.
    Connelly RT, Lourwood DL.
    Pharmacotherapy; 1994 Oct; 14(4):424-9. PubMed ID: 7937279
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers?
    Bennett CL, Oddone E, Matchar D.
    Clin Perform Qual Health Care; 1995 Oct; 3(3):156-64. PubMed ID: 10151167
    [Abstract] [Full Text] [Related]

  • 15. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
    El-Sadr WM, Murphy RL, Yurik TM, Luskin-Hawk R, Cheung TW, Balfour HH, Eng R, Hooton TM, Kerkering TM, Schutz M, van der Horst C, Hafner R.
    N Engl J Med; 1998 Dec 24; 339(26):1889-95. PubMed ID: 9862944
    [Abstract] [Full Text] [Related]

  • 16. [New aspects of epidemiology and treatment of Pneumocystis carinii infection].
    Powierska-Czarny J, Gospodarek E, Czerwionka-Szaflarska M.
    Pol Merkur Lekarski; 2004 Nov 24; 17(101):534-7. PubMed ID: 15754652
    [Abstract] [Full Text] [Related]

  • 17. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
    Masur H, Kovacs JA.
    Infect Dis Clin North Am; 1988 Jun 24; 2(2):419-28. PubMed ID: 3060526
    [Abstract] [Full Text] [Related]

  • 18. [Sulfamethoxazole-trimethoprim-induced pneumonitis in a patient with hemophilia B who was infected with the human immunodeficiency virus].
    Yamagishi T, Yoshida S, Fukutake K, Utsumi K, Ichinose Y.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul 24; 34(7):822-8. PubMed ID: 8810766
    [Abstract] [Full Text] [Related]

  • 19. Pneumocystis carinii pneumonia prophylaxis with atovaquone in trimethoprim-sulfamethoxazole-intolerant orthotopic liver transplant patients: a preliminary study.
    Meyers B, Borrego F, Papanicolaou G.
    Liver Transpl; 2001 Aug 24; 7(8):750-1. PubMed ID: 11510024
    [Abstract] [Full Text] [Related]

  • 20. Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia.
    Madden RM, Pui CH, Hughes WT, Flynn PM, Leung W.
    Cancer; 2007 Apr 15; 109(8):1654-8. PubMed ID: 17345613
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.